UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

A randomized placebo-controlled trial of a humanized monoclonal antibody to α4 integrin in active crohn's disease

Gastroenterology (New York, N.Y. 1943), 2001-08, Vol.121 (2), p.268-274

2001

Volltextzugriff (PDF)

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

Blood, 2007-08, Vol.110 (4), p.1123-1131

2007

Volltextzugriff (PDF)

A phase I trial of epstein-barr virus gp350 vaccine for children with chronic kidney disease awaiting transplantation

Transplantation, 2009-10, Vol.88 (8), p.1025

2009

Volltextzugriff (PDF)

Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells

The Lancet (British edition), 2002-08, Vol.360 (9331), p.436-442

2002

Volltextzugriff (PDF)

Incubation Phase of Acute Hepatitis B in Man: Dynamic of Cellular Immune Mechanisms

Hepatology (Baltimore, Md.), 2000-11, Vol.32 (5), p.1117-1124

2000

Volltextzugriff (PDF)

A quantitative assay for Epstein-Barr Virus-specific immunity shows interferon-gamma producing CD8+ T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease

Transplantation, 2007-12, Vol.84 (11), p.1534

2007

Volltextzugriff (PDF)

Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells

Transplantation, 2001-10, Vol.72 (8), p.1399

2001

Volltextzugriff (PDF)

Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases

Journal of immunotherapy (1997), 2004-07, Vol.27 (4), p.309

2004

Volltextzugriff (PDF)

Reconstitution of EBV-Specific T Cell Immunity in Solid Organ Transplant Recipients

The Journal of immunology (1950), 1998-06, Vol.160 (12), p.6204-6209

1998

Volltextzugriff (PDF)

Disappearance of an Epstein-Barr virus-positive post-transplant plasmacytoma with reduction of immunosuppression

The Lancet (British edition), 1998-09, Vol.352 (9130), p.789-789

1998

Volltextzugriff (PDF)

Rapamycin-induced remission of Kaposi's sarcoma is not associated with expansion of cytotoxic T-lymphocyte subsets

Clinical kidney journal, 2008-10, Vol.1 (5), p.313-315

2008

Volltextzugriff (PDF)

Pharmaceutical development of immunosuppression in transplantation

Journal of pharmacy and pharmacology, 1998-09, Vol.50 (S9), p.34-34

Amlot, Peter L.

1998

Volltextzugriff (PDF)

Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia

Nature genetics, 1997-09, Vol.17 (1), p.96-99

1997

Volltextzugriff (PDF)

Splenic dependence of the antibody response to thymus‐independent (TI‐2) antigens

European journal of immunology, 1985, Vol.15 (5), p.508-512

1985

Volltextzugriff (PDF)

Follicular dendritic cells share a membrane-bound protein with fibroblasts

The Journal of pathology, 2000-06, Vol.191 (2), p.217-226

2000

Volltextzugriff (PDF)

Clustering of missense mutations in the ataxia-telanglectasia gene in a sporadic T-cell leukaemia

Nature genetics, 1997-09, Vol.17 (1), p.96-99

1997

Volltextzugriff (PDF)

Somatically mutated regions of immunoglobulin on human b-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells

Cancer research (Chicago, Ill.), 2001-07, Vol.61 (13), p.5145-5152

2001

Volltextzugriff (PDF)

Patterns of natural killer cell and T cell activation marker expression in inflammatory bowel disease (IBD)

Gastroenterology (New York, N.Y. 1943), 2000-04, Vol.118 (4), p.A1343-A1343

2000

Volltextzugriff (PDF)

Inhibition of alloresponsive naive and memory T cells by CD7 and CD25 antibodies and by cyclosporine

Transplantation, 1990-11, Vol.50 (5), p.823

1990

Volltextzugriff (PDF)

The effect of a chimeric mouse-human CD7 antibody on human T, natural killer, and lymphokine-activated killer cell activity in vitro

Transplantation, 1991-08, Vol.52 (2), p.325

1991

Volltextzugriff (PDF)

Neoepitopes expressed by immune complexes

Complement and inflammation, 1989, Vol.6 (3), p.236

Amlot, P L

1989

Volltextzugriff (PDF)

Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy

Clinical cancer research, 1995-12, Vol.1 (12), p.1623-1634

1995

Volltextzugriff (PDF)

V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia

Haematologica (Roma), 2003-11, Vol.88 (11), p.1259

2003

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(4)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A randomized placebo-controlled trial of a humanized monoclonal antibody to α4 integrin in active crohn's disease

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

A phase I trial of epstein-barr virus gp350 vaccine for children with chronic kidney disease awaiting transplantation

Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells

Incubation Phase of Acute Hepatitis B in Man: Dynamic of Cellular Immune Mechanisms

A quantitative assay for Epstein-Barr Virus-specific immunity shows interferon-gamma producing CD8+ T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease

Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells

Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases

Reconstitution of EBV-Specific T Cell Immunity in Solid Organ Transplant Recipients

Disappearance of an Epstein-Barr virus-positive post-transplant plasmacytoma with reduction of immunosuppression

Rapamycin-induced remission of Kaposi's sarcoma is not associated with expansion of cytotoxic T-lymphocyte subsets

Pharmaceutical development of immunosuppression in transplantation

Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia

Splenic dependence of the antibody response to thymus‐independent (TI‐2) antigens

Follicular dendritic cells share a membrane-bound protein with fibroblasts

Clustering of missense mutations in the ataxia-telanglectasia gene in a sporadic T-cell leukaemia

Somatically mutated regions of immunoglobulin on human b-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease : results of a phase 2 multicenter clinical trial. Commentary

Patterns of natural killer cell and T cell activation marker expression in inflammatory bowel disease (IBD)

Inhibition of alloresponsive naive and memory T cells by CD7 and CD25 antibodies and by cyclosporine

The effect of a chimeric mouse-human CD7 antibody on human T, natural killer, and lymphokine-activated killer cell activity in vitro

Neoepitopes expressed by immune complexes

Implementing Germ Defence digital behaviour change intervention via all primary care practices in England to reduce respiratory infections during the COVID-19 pandemic: an efficient cluster randomised controlled trial using the OpenSAFELY platform

Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy

V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia

Suchergebnisse filtern